A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of 2 doses of ustekinumab
compared with placebo (inactive medication) in adult Japanese participants with severe atopic
dermatitis.